MPZL3 and obesity due to melanocortin 4 receptor deficiency: Interestingly, we also observed decreased RER (Figure 4e,f) indicating that the acute anti‐obesity effects of Mpzl3 ASO were likely due, in part, to increased whole‐body fat oxidation.